You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Rasburicase

Showing 1 - 25 of 35
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Gout Trial in Foshan, Guangzhou, Shanwei (Rasburicase)

Not yet recruiting
  • Chronic Gout
  • Rasburicase
  • Foshan, Guangdong, China
  • +2 more
May 4, 2022

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Tumor Lysis Syndrome Trial in Houston (Pegloticase, Rasburicase)

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Leukemia, Lymphoma Trial in Houston (Rasburicase, Allopurinol)

Completed
Has Results
  • Leukemia
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 23, 2020

Oxidative Stress, Endothelial Function, Cardiovascular System Trial in Brussels (Placebos, Febuxostat, Rasburicase)

Completed
  • Oxidative Stress
  • +3 more
  • Placebos
  • +2 more
  • Brussels, Belgique, Belgium
    Erasme Hospital
Feb 27, 2020

Fractionated Rituximab to Avoid Lysis Syndrome in Aggressive

Active, not recruiting
  • Aggressive B-Cell Non-Hodgkin Lymphoma
  • fractionated first dose rituximab
  • Geneva, Switzerland
    University Hospital Geneva
Apr 21, 2023

Lymphoid Malignancies Trial in United States (AVM0703)

Recruiting
  • Lymphoid Malignancies
  • Duarte, California
  • +6 more
Nov 14, 2022

Hyperuricemia Trial in Qingdao (Polyglycol lated urate oxidase for injection, Placebo)

Recruiting
  • Hyperuricemia
  • Polyglycol lated urate oxidase for injection
  • Placebo
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University
Feb 4, 2022

Hyperuricemia, Gout, Chronic Kidney Diseases Trial in United States (ALLN-346, Placebo)

Recruiting
  • Hyperuricemia
  • +2 more
  • Birmingham, Alabama
  • +16 more
Dec 2, 2021

Hyperuricemia Trial in Cincinnati (ALLN-346, Placebo)

Completed
  • Hyperuricemia
  • Cincinnati, Ohio
    Medpace Clinical Pharmacology
Jul 19, 2021

Hyperuricemia, Gout Trial in Cincinnati (ALLN-346, Placebo)

Completed
  • Hyperuricemia
  • Gout
  • Cincinnati, Ohio
    Medpace Clinical Pharmacology
Jun 29, 2021

Hyperuricemia, Gout Trial in Tempe (ALLN-346, Placebo)

Recruiting
  • Hyperuricemia
  • Gout
  • Tempe, Arizona
    Celerion
Aug 2, 2021

Gout Trial in Guangzhou (PEGylated recombinant candida urate oxidase)

Recruiting
  • Gout
  • PEGylated recombinant candida urate oxidase
  • Guangzhou, Guangdong, China
    The Fifth Affiliated Hospital of Guangzhou Medical University
Jul 2, 2021

T-Cell Lymphoma Relapsed, T-Cell Lymphoma Refractory Trial in Italy (Venetoclax)

Active, not recruiting
  • T-Cell Lymphoma Relapsed
  • T-Cell Lymphoma Refractory
  • Aviano, Italy
  • +12 more
Dec 20, 2022

Obesity, Metabolic Syndrome, Hyperuricemia Trial in Saint Louis (Rasburicase)

Completed
Has Results
  • Obesity
  • +2 more
  • Rasburicase
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 16, 2018

Healthy Volunteers Trial in Baltimore (IV Uric Acid, IV Rasburicase)

Completed
  • Healthy Volunteers
  • IV Uric Acid
  • IV Rasburicase
  • Baltimore, Maryland
    National Institute of Aging, Clinical Research Unit
Jul 3, 2018

Adverse Drug Reaction Trial in Indianapolis (Pharmacogenetic Intervention Arm (pharmacogenetic testing))

Completed
  • Adverse Drug Reaction
  • Pharmacogenetic Intervention Arm (pharmacogenetic testing)
  • Indianapolis, Indiana
    Eskenazi Health System
Jan 6, 2021

Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Boston (drug, procedure, radiation)

Completed
Has Results
  • Chronic Myeloproliferative Disorders
  • +6 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Apr 20, 2017

Chemotherapy or Malignancy-Induced Hyperuricemia in

Completed
  • Leukemia
  • +3 more
  • Rasburicase
  • Palo Alto, California
  • +10 more
Apr 24, 2017

Hyperuricemia Trial in Hyd (TULY)

Completed
  • Hyperuricemia
  • Hyd, Andhra Pradesh, India
    Dr. Raghunathrao
Dec 11, 2014

Childhood Burkitt Lymphoma, Childhood Diffuse Large Cell Lymphoma, Childhood Immunoblastic Large Cell Lymphoma Trial in Arcadia

Completed
Has Results
  • Childhood Burkitt Lymphoma
  • +11 more
  • doxorubicin hydrochloride
  • +13 more
  • Arcadia, California
    Children's Oncology Group
Sep 10, 2014

Hyperuricemia Trial in Shanghai (Rasburicase, Allopurinol)

Terminated
  • Hyperuricemia
  • Shanghai, China
    Sanofi-Aventis Administrative Office
May 7, 2014

Tumor Lysis Syndrome Trial in Houston (As Needed Rasburicase, Fixed Dose Rasburicase)

Completed
Has Results
  • Tumor Lysis Syndrome
  • As Needed Rasburicase
  • Fixed Dose Rasburicase
  • Houston, Texas
    UT MD Anderson Cancer Center
May 31, 2013

Elitek (Rasburicase) Immuno-Monitoring Study

Terminated
  • Tumor Lysis Syndrome
    • Valhalla, New York
    • +3 more
    Jan 30, 2013

    Leukemia, Lymphoma, Tumor Lysis Syndrome Trial in Houston (Rasburicase)

    Completed
    • Leukemia
    • +2 more
    • Rasburicase
    • Houston, Texas
      The University of Texas M.D. Anderson Cancer Center
    Jul 31, 2012

    Hyperuricemia Trial in Gainesville (Rasburicase, Placebo)

    Completed
    Has Results
    • Hyperuricemia
    • Rasburicase
    • Placebo
    • Gainesville, Florida
      University of Florida
    Aug 1, 2012